Outcome of COVID-19 in Egyptian living-donor kidney transplant recipients and relation to maintenance immunosuppressive drugs: a pilot study
Abstract Coronavirus disease 2019 (COVID-19) in kidney transplant recipients is a subject of much debate and became of interest to nephrologists amidst the pandemic. The main concerns are the influence of the chronic use of immunosuppressive drugs, the viral-related risk of acute rejection, and the...
Main Authors: | Maggie Said ElNahid, Marianne Samir Makboul Issac, Khaled Marzouk Sadek |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-45750-8 |
Similar Items
-
Author Correction: Outcome of COVID-19 in Egyptian living-donor kidney transplant recipients and relation to maintenance immunosuppressive drugs: a pilot study
by: Maggie Said ElNahid, et al.
Published: (2023-12-01) -
Serum Phosphorus, Parathyroid Hormone, and Serum Fibroblast Growth Factor-23 in Egyptian Patients Six Months after Undergoing Living-donor Kidney Transplantation
by: Mai Hamed Kamel, et al.
Published: (2022-01-01) -
Association of IL-1β rs16944 and IL-1RN rs2234663 gene polymorphisms with graft function in renal transplant recipients
by: Marianne Samir Makboul Issac, et al.
Published: (2023-10-01) -
Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
by: Danae Olaso, et al.
Published: (2021-08-01) -
Use of Donor-derived Cell-free DNA to Inform Tapering of Immunosuppression Therapy in Kidney Transplant Recipients: An Observational Study
by: George Osuchukwu, MD, et al.
Published: (2024-04-01)